The Centers for Disease Control (CDC) has added type 1 diabetes (T1D) as one of the medical conditions associated with higher risk for severe COVID-19. Click here for the full list.

BREAKING DOWN THE SCIENCE:  The T1D and COVID-19 Surveillance Study

In March of 2020, T1D Exchange quickly recognized — along with the rest of the country — that COVID-19 was spreading rapidly throughout the nation. With so little information on how it might impact people with chronic illnesses like type 1 diabetes (T1D), we realized there was an opportunity and a responsibility to facilitate some form of research and surveillance of its effects on this population.

The urgency was clear: a protocol was written and submitted to the Institutional Review Board and approved in a record-breaking two hours. Read the full article.